BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Colbath AC, Dow SW, Hopkins LS, Phillips JN, Mcilwraith CW, Goodrich LR. Allogeneic vs. autologous intra‐articular mesenchymal stem cell injection within normal horses: Clinical and cytological comparisons suggest safety. Equine Vet J 2019;52:144-51. [DOI: 10.1111/evj.13136] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Kouchakian MR, Baghban N, Moniri SF, Baghban M, Bakhshalizadeh S, Najafzadeh V, Safaei Z, Izanlou S, Khoradmehr A, Nabipour I, Shirazi R, Tamadon A. The Clinical Trials of Mesenchymal Stromal Cells Therapy. Stem Cells Int 2021;2021:1634782. [PMID: 34745268 DOI: 10.1155/2021/1634782] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zayed M, Adair S, Dhar M. Effects of Normal Synovial Fluid and Interferon Gamma on Chondrogenic Capability and Immunomodulatory Potential Respectively on Equine Mesenchymal Stem Cells. Int J Mol Sci 2021;22:6391. [PMID: 34203758 DOI: 10.3390/ijms22126391] [Reference Citation Analysis]
3 Andia I, Maffulli N. Mesenchymal stromal cell products for intra-articular knee injections for conservative management of osteoarthritis. Ther Adv Musculoskelet Dis 2021;13:1759720X21996953. [PMID: 33680097 DOI: 10.1177/1759720X21996953] [Reference Citation Analysis]
4 Colbath AC, Dow SW, Hopkins LS, Phillips JN, McIlwraith CW, Goodrich LR. Single and repeated intra-articular injections in the tarsocrural joint with allogeneic and autologous equine bone marrow-derived mesenchymal stem cells are safe, but did not reduce acute inflammation in an experimental interleukin-1β model of synovitis. Equine Vet J 2020;52:601-12. [PMID: 31821594 DOI: 10.1111/evj.13222] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Kamm JL, Riley CB, Parlane NA, Gee EK, McIlwraith CW. Immune response to allogeneic equine mesenchymal stromal cells. Stem Cell Res Ther 2021;12:570. [PMID: 34772445 DOI: 10.1186/s13287-021-02624-y] [Reference Citation Analysis]
6 Colbath AC, Dow SW, McIlwraith CW, Goodrich LR. Mesenchymal stem cells for treatment of musculoskeletal disease in horses: Relative merits of allogeneic vs autologous stem cells. Equine Vet J. 2020;52:654-663. [PMID: 31971273 DOI: 10.1111/evj.13233] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
7 Aldrich ED, Cui X, Murphy CA, Lim KS, Hooper GJ, McIlwraith CW, Woodfield TBF. Allogeneic mesenchymal stromal cells for cartilage regeneration: A review of in vitro evaluation, clinical experience, and translational opportunities. Stem Cells Transl Med 2021. [PMID: 34387402 DOI: 10.1002/sctm.20-0552] [Reference Citation Analysis]
8 Popowski K, Lutz H, Hu S, George A, Dinh PU, Cheng K. Exosome therapeutics for lung regenerative medicine. J Extracell Vesicles 2020;9:1785161. [PMID: 32944172 DOI: 10.1080/20013078.2020.1785161] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
9 Kamm JL, Riley CB, Parlane N, Gee EK, McIlwraith CW. Interactions Between Allogeneic Mesenchymal Stromal Cells and the Recipient Immune System: A Comparative Review With Relevance to Equine Outcomes. Front Vet Sci 2020;7:617647. [PMID: 33521090 DOI: 10.3389/fvets.2020.617647] [Reference Citation Analysis]
10 Rowland AL, Burns ME, Levine GJ, Watts AE. Preparation Technique Affects Recipient Immune Targeting of Autologous Mesenchymal Stem Cells. Front Vet Sci 2021;8:724041. [PMID: 34595230 DOI: 10.3389/fvets.2021.724041] [Reference Citation Analysis]